Skip to main content

Is Molnupiravir really a game-changer for Coronavirus?

Drug companies are continuing in making dollars even 1.5 years after the eruption of a pandemic virus. World Health Organization (WHO) warns cases and deaths increasing in European nations. Some noted healthcare companies are involved to earn money as much as they can. WHO predicts that the EU continent could experience half a million deaths in the coming three months. When the first wave was really severe, many opined that remdesivir should make difference to combat coronavirus. During the COVID-19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in around 50 countries. The first oral tablet was developed for the treatment of symptomatic COVID-19 patients.


Now, the new game-changer “Molnupiravir” is going to hit the market. EU registered a 55% rise in COVID-19 cases despite the availability of vaccines. All these were giving boosters and preventing the human body to get infected. Till now no pharmacy company found a permanent solution for coronavirus. The United Kingdom approves oral pill Molnupiravir to treat coronavirus which has been developed by US-based Merck. The UK is the first nation in the world to approve the coronavirus antiviral pill. It has agreed to buy 480k courses with the first deliveries expected in November. The US also gave advance payment for the purchase of 1.7 million of the pill. It is also similar to earlier vaccines in giving a boost to the fight against the covid-19 pandemic. The only difference is earlier vaccines are injected into the human body through a needle but Molnupiravir is an oral one to take.


Health officials said that the pill will initially give to both vaccinated and unvaccinated patients. Patients would use the oral pill within 5 days of symptoms developing to be most effective. The pill was initially developed to treat flu. There are persistent side-effect concerns with mutagenic molnupiravir. The pill would reduce the risk of hospitalization or death by about half. Merck said that no deaths were reported after the treatment with Molnupiravir pill. Pfizer says antiviral pills cut the risk of severe COVID-19 by 89%. Merck seeks FDA authorization for the coronavirus treatment pill. It says that the treatment is likely to be effective against new variants of the virus. 

Labels:

Comments

Post a Comment

Popular posts from this blog

Photo : Savitri during her last days

Even after 4 decades of her death, people are very much interested to watched her (Savitri) biopic. Mahanati turned to be stupendous success. On eve of remembering Savitri, here we posted Savitri photo. The photo seems her last days. The man stand behind Savitri is Gemini Ganeshan who married Savitri. It seems that she suffered bad days during her last days.
Post a Comment
Read more

Jagan angry on Avanthi Srinivas on Bhimili meeting!

Avanthi Srinivas was joined in YSRCP in January this year. Avanthi joined in YSRCP seeking to contest as Bhimili Assembly segment in 2019 General Elections.
Post a Comment
Read more

Producers demand 18 crores for Ceded for Pavan and Trivikram film

Director Rajamouli showed the path to all other producers on how to sell product (movie) in different ways across the word. Telugu Cinema has vertically divided in two ways Before and after Bahubali. Bahubali proves that there were no boundaries in selling the movie. Other producers who are doing with star heros like Pavan, Mahesh and Jr. NTR will follow Rajamouli in this regard. But there is slight difference with Bahubali and other heros films. Unfortunately, producers and distributors fail to notice the gap. Bahubali is universal movie which was apt to all sections in the world. That is the reason for getting huge collections across the world. We didn't expect the same situation for Prabas's next movie even though his popularity increased with Bahubali. Radha Krishna who produced movies like Julayi and A. AA.. will plan to produce next film with Pavan and Trivikram. Movie was not yet started but distributors rushed toward producer for getting area-wise rights.Obviously, ...
Post a Comment
Read more